QualityStocksNewsBreaks Archives - Page 633 of 1503

TuesdayOct 12, 2021 10:47 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Files International Patent Application in Continued Expansion of IP Portfolio

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, announced that it has filed an international patent application related to methods for the delivery of psychedelic medications by inhalation and devices for performing those methods. According to the update, the application, governed by the Patent Cooperation Treaty (“PCT”), brings the potential to obtain patent coverage in 153 countries. “The continued progression of our research programs guides our discovery of new molecules and differentiating treatment approaches,” said Doug Drysdale, the company’s CEO. “Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading…

TuesdayOct 12, 2021 10:46 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Receives Cannabis Cultivation License, Commences Grow Operations

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that its subsidiary, Red White & Bloom Florida LLC, has received approval to begin growth operations at its 45,000-square-foot greenhouse in Apopka, Florida. The company has completed phase one of its cultivation strategy and is in the midst of a three-phase development plan for two Florida cultivation centers. The centers are part RWBYF’s plan to produce adequate inventory for existing and new dispensary openings planned for Q1 2022. The company had plants at the greenhouse ready to plant as soon as approval…

TuesdayOct 12, 2021 10:26 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) Announces Results of Annual General and Special Meeting

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) and/or its subsidiaries, a software-as-a-service (“SaaS”) technology company focused on delivering mobile live dealer technology to online gaming operators globally, today announced that each of the matters set forth in the company’s management information circular dated Sept. 10, 2021, were approved by the company’s shareholders at its annual general and special meeting. The matters put forth for approval by the shareholders at the meeting held on Oct. 8, 2021, included: (i) the election of Darcy Krogh, Guido Ganschow, James Penturn, Michele (Mike) Marrandino, William Scott and Jason Meretsky as directors of the company, (ii)…

TuesdayOct 12, 2021 9:55 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Launches Campaigns to Scale Fan Pass Platform, Attract Artists Across Multiple Genres

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced the official launch of its digital advertising and social media campaigns, aimed at attracting artists across various music genres. Entering the fourth quarter of 2021, the company’s Fan Pass platform has begun extending its brand awareness and artist offering to various artist groups and genre-specific targets that include industry managers, venues and music-related booking services. “As we enter the final quarter of the year, we have our sights set on testing, converting and growing our artist and fan bases. At the same time, we continue monetizing our service offering…

MondayOct 11, 2021 2:22 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices

RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate dosing protocols: routine administration, conservative administration and rapid administration, with each designed to ease a patient treating chronic pain into medical cannabis and treatment with THC if needed. Such dosing guidelines are just half of the equation. The other half is the delivery mechanism, as…

MondayOct 11, 2021 1:40 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical property and has achieved significant results,” reads a recent article. AnPac Bio has one of the largest sample libraries in the world, with more than 220,000 samples…

MondayOct 11, 2021 1:26 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Preparing for Clinical Trials Amid Growing Push for New Federally Approved Therapeutic

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) expects to soon launch a phase 2a clinical trial to determine the efficacy of its psychedelic drug candidate TRP-8802 in treating Prader-Willi Syndrome, hypothalamic obesity eating disorder resulting from removal of a brain tumor, and binge eating disorder. According to a recent article, TRP-8802 will be used in combination with psychotherapy under professional care to create the proper mindset for the neuroplasticity benefits of psilocybin to take full effect. Tryp then plans to proceed into phase 2b clinical trials with drug candidate TRP-8803 to test the trademarked product’s ability to penetrate the natural blood-brain…

MondayOct 11, 2021 1:08 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Poised Amid New Research Surrounding Psilocybin

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is likely to benefit from new research touting psilocybin mental health treatments. According to recent news from a group of Yale researchers, psilocybin has been found to counteract symptoms of depression (https://ibn.fm/NCORl). “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin can cause structural changes in the brain that counteract symptoms of depression,” reads a recent article quoting a Yale Daily News publication titled “Yale Researchers Discover Healing Effects of Psychedelic Drug.” In the piece published…

MondayOct 11, 2021 12:11 pm

QualityStocksNewsBreaks – PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Unveiling of Squamish ‘XMarket’ to Feature Vegan Barbecue, New Mural and High-Profile Ambassadors

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has marked many recent achievements and is focused on completing several key milestones for a strong remainder of the 2021 fiscal year. Among these, PlantX is focused on an ongoing retail branding initiative to rename its existing brick-and-mortar stores as “XMarket.” The new identity intends to reflect the dynamic, interactive and diverse in-store experience provided by the company’s physical retail locations. Currently, PlantX has physical stores in British Columbia, Squamish, and Venice Beach, California, all of which will be re-branded as XMarket. “The official unveiling of XMarket in Squamish, British Columbia,…

MondayOct 11, 2021 12:00 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Helping People Get Hearing Aids at Fraction of Cost

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is committed to changing the lives of millions of Americans with hearing impairment, helping them get the hearing aids they need at a fraction of the cost set by traditional hearing clinics. “The costs of one hearing aid alone can range from $1,000 to as much as $6,000, not including additional expenses that can occur, such as hearing tests, follow-ups and ongoing support from healthcare professionals,” reads a recent article. One of the key drivers of these prohibitive costs is that consumers must…

Site Search

Company Search

Category: QualityStocksNewsBreaks